ETFs positioned on Nipro Corporation

Name YTD change Weight AuM
+1.17%-.--% 51 M€
+22.93%-.--% 7,349 M€
+12.69%-.--% 5,871 M€
+6.33%-.--% 49 M€
+1.93%0.25% 94 M€
+18.77%0.25% 19,658 M€
+19.45%0.13% 623 M€
+20.14%0.12% 263 M€
+14.68%0.09% 3,151 M€
+20.60%0.08% 399 M€
+11.89%0.06% 366 M€
+13.56%0.06% 918 M€
+3.06%0.05% 28 M€
+11.04%0.04% 13,445 M€
+10.90%0.04% 258 M€
+17.18%0.04% 11 M€
-.--%0.04% 3 M€
-.--%0.04% 0 M€
+6.96%0.04% 429 M€
+22.58%0.04% 134 M€
+22.34%0.04% 127 M€
+24.13%0.04% 495 M€
+19.20%0.04% 28 M€
-.--%0.03% 19 M€
+19.75%0.03% 151 M€
+20.85%0.03% 121 M€
+14.57%0.03% 2,014 M€
+24.56%0.03% 8,317 M€
+20.91%0.03% 67 M€
+23.99%0.03% 115 M€
+22.07%0.03% 40 M€
+17.17%0.03% 18,403 M€
+12.31%0.03% 45 M€
+21.15%0.03% 141 M€
+24.64%0.03% 473 M€
+21.94%0.03% 42 M€
+21.10%0.03% 204 M€
+24.07%0.03% 3,314 M€
+21.99%0.03% 97 M€
+10.06%0.03% 361 M€
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
  1. Stock Market
  2. Stocks
  3. 8086 Stock
  4. ETFs Nipro Corporation
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!